Heimdall Insights

Global Pharmacogenomics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Pharmacogenomics Market was valued at $10.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 10.7% CAGR, to an estimated market size of $16.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The pharmacogenomics market involves the study and application of how an individual's genetic makeup influences their response to drugs, encompassing the development and sale of testing kits, reagents, software, and services. The scope includes technologies like Next-Generation Sequencing (NGS) and PCR used to optimize drug selection and dosage, improve therapeutic efficacy, and minimize adverse drug reactions (ADRs) across clinical and research settings.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Pharmacogenomics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Oncology
  • Neurology & Psychiatry
  • Cardiology
  • Pain Management
  • Other Applications